ADCs, AOCs, ATMPs, cell and gene therapies, and oligonucleotide therapeutics represent distinct but interconnected approaches to precision medicine. Let's take a closer look at their manufacturing needs.
- Developing Your Vapor Phase Hydrogen Peroxide Cycle
- Closing The Gap Between Modeling And GMP Predictive Control
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
- Want More Sustainable Biopharma Packaging? Try These Levers
- What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
- Fine-Tuning Bioseparation Column Geometry With 3D-Printed Monoliths
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Evaluating Antibody Fragment Purification Using VH3 Resin
Explore how VH-domain targeting enables efficient purification of VH3 antibody fragments and bispecific formats, with strong recoveries and flexible wash conditions that support improved purity.
-
A Shift Towards Biofluorescent Particle Counters In Manufacturing
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
-
A End-To-End Solution For Robust Large-Scale CAR T Manufacturing
Automated, closed-system workflows are reshaping CAR T manufacturing, compressing multi-week processes into days while preserving critical functional attributes of the final cell product.
-
Streamlining Pediatric Clinical Trials With Vestigo®
Utilizing a centralized, automated platform can eliminate the friction of manual accountability logs, ensuring audit readiness while providing real-time visibility into financial reporting.
-
Revealing Hidden Integration Events With TLA And Nanopore Sequencing
When standard methods fell short, a biotech company used advanced analysis to confirm targeted construct integration and detect hidden genome changes.
-
Rescue Treatment Design In Wet AMD And Retinal Vascular Trials
How trials protect vision without muddying the data: explore the five design choices behind an effective rescue treatment strategy.
-
Why Bridging Cleanroom Infrastructure And Process Equipment Design Is Critical
Conflicting regulations and poor design can misalign cleanroom mechanical systems with process equipment, creating contamination risks, compromising product quality, and delaying facility startup.
-
Enhanced mAb Production With High-Intensity Perfusion CHO Medium
Reach new heights in mAb production with a high-intensity perfusion CHO medium designed to support consistently high product yield and quality in continuous perfusion cultures using CHO-K1 cells.
-
Manufacturing of "MSC 2.0" Using Functionally Closed Systems
Transitioning to closed systems enables the 100-fold expansion of engineered cells. Achieve high yields and maintain anti-cancer potency while reducing contamination risks and labor.
-
Expansion Of Human Umbilical Cord-Derived MSCs
Discover how high-quality, multipotent stromal cells are efficiently produced for regenerative medicine. Learn about their impressive viability and critical marker expression for therapeutic uses.
NEWSLETTER ARCHIVE
- 11.14.26 -- Cell & Gene Newsletter - Best of October
- 11.13.26 -- Closing The CAR-T Access Gap With Hospital-Based Manufacturing
- 11.12.26 -- A New Model For Bringing CAR-T To More Patients
- 11.12.26 -- Simplify The Journey Of Advancing Your Therapies To Patients
- 11.12.26 -- The Latest CDMO Opportunities And Threats Report
- What Will It Take To Turn CGT Innovation Into Market Success?
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

